Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

Introduction: Real-world evidence (RWE) in health technology assessment (HTA) holds significant potential for informing healthcare decision-making. A multistakeholder workshop was organised by the European Health Data and Evidence Network (EHDEN) and the GetReal Institute to explore the status, chal...

Full description

Bibliographic Details
Main Authors:	Ravinder Claire, Jamie Elvidge, Shahid Hanif, Hannah Goovaerts, Peter R. Rijnbeek, Páll Jónsson, Karen Facey, Dalia Dawoud
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pharmacology
Subjects:	health technology assessment regulatory real world evidence real world data common data model federated data network
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1289365/full

Similar Items

Real-World Evidence Gathering in Oncology: The Need for a Biomedical Big Data Insight-Providing Federated Network
by: Tine Geldof, et al.
Published: (2019-03-01)

Real-world evidence for regulatory decision-making: updated guidance from around the world
by: Leah Burns, et al.
Published: (2023-10-01)

Developing real‐world evidence from real‐world data: Transforming raw data into analytical datasets
by: Lisa Bastarache, et al.
Published: (2022-01-01)

Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”
by: Jiahe Li, et al.
Published: (2023-01-01)

Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
by: Patrick Maison, et al.
Published: (2022-07-01)

The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data
by: Frank Grimberg, et al.
Published: (2021-06-01)

Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications
by: Zou KH, et al.
Published: (2020-07-01)

Worldwide Trends in Registering Real-World Studies at ClinicalTrials.gov: A Cross-Sectional Analysis
by: Li Y, et al.
Published: (2023-03-01)

Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments
by: Eleni Kokkotou, et al.
Published: (2024-04-01)

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer
by: Caroline Muñoz, et al.
Published: (2024-03-01)

Real World Evidence: methodological issues and opportunities from the European Health Data Space
by: Stelios Kympouropoulos
Published: (2023-08-01)

Statins and Colorectal Cancer Risk: A Population-Based Case-Control Study and Synthesis of the Epidemiological Evidence
by: Antonio Rodríguez-Miguel, et al.
Published: (2022-03-01)

Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases
by: Ye-Seul Lee, et al.
Published: (2023-12-01)

A survey of United States adult privacy perspectives and willingness to share real-world data
by: Rachele M. Hendricks-Sturrup, et al.
Published: (2023-01-01)

How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
by: Robbe Saesen, et al.
Published: (2022-08-01)

A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence
by: Kristoffer Larsen, et al.
Published: (2023-10-01)

Guy’s cancer cohort – real world evidence for cancer pathways
by: C. Moss, et al.
Published: (2020-03-01)

Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
by: Yoon Duk Hong, et al.
Published: (2021-12-01)

Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective
by: Allison Wills, et al.
Published: (2023-10-01)

Editorial: Real-world data and real-world evidence in hematologic malignancies
by: Michele Malagola, et al.
Published: (2023-06-01)

Laying the Foundation for Real-World Evidence Studies of Psoriatic Disease in Newfoundland and Labrador
by: Winifred Badaiki, et al.
Published: (2022-09-01)

An application of the Causal Roadmap in two safety monitoring case studies: Causal inference and outcome prediction using electronic health record data
by: Brian D. Williamson, et al.
Published: (2023-01-01)

Real-world evidence in achondroplasia: considerations for a standardized data set
by: Yasemin Alanay, et al.
Published: (2023-06-01)

Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
by: Hideki Maeda, et al.
Published: (2022-04-01)

A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data
by: Wang SV, et al.
Published: (2022-04-01)

A brief introduction to research based on real-world evidence: Considering the Korean National Health Insurance Service database
by: Eun Kyoung Ahn
Published: (2022-06-01)

The evolving role of data & safety monitoring boards for real-world clinical trials
by: Bryan J. Bunning, et al.
Published: (2023-01-01)

Pharmacoepidemiology Research-Real-World Evidence for Decision Making
by: Anick Bérard, et al.
Published: (2021-09-01)

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS
by: Kostka K, et al.
Published: (2022-03-01)

Conversion of CPRD AURUM data into the OMOP common data model
by: Craig S. Mayer
Published: (2023-01-01)

Editorial: From clinical trials to real-world data sciences for value in health: access, utilization, and quality
by: Xiangxiang Jiang, et al.
Published: (2023-05-01)

Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process
by: Konstantinos Zisis, et al.
Published: (2024-02-01)

Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments
by: Carlos Loucera, et al.
Published: (2023-10-01)

Status of Medications Prescribed for Psychiatric Disorders in Korean Pediatric and Adolescent Patients
by: In-Woo Jang, et al.
Published: (2022-01-01)

A Survey of Research Participants’ Privacy-Related Experiences and Willingness to Share Real-World Data with Researchers
by: Rachele M. Hendricks-Sturrup, et al.
Published: (2022-11-01)

Evaluation of reporting quality of cohort studies using real-world data based on RECORD: systematic review
by: Ran Zhao, et al.
Published: (2023-06-01)

Editorial: The use of real world data for regulatory purposes in the rare diseases setting
by: Viviana Giannuzzi, et al.
Published: (2022-11-01)

Editorial: Real world evidence, outcome research and healthcare management improvement through real world data (RWD)
by: Carolina Varela-Rodríguez, et al.
Published: (2023-01-01)

Transferability of real-world data across borders for regulatory and health technology assessment decision-making
by: Ashley Jaksa, et al.
Published: (2022-11-01)

Knocking on heaven's door: The gap between health institutions and academies in generating knowledge utilizing real-world data
by: Giovanni Corrao, et al.
Published: (2022-10-01)